...
首页> 外文期刊>International reviews of immunology >Targeting the TCR: T-cell receptor and peptide-specific tolerance-based strategies for restoring self-tolerance in CNS autoimmune disease.
【24h】

Targeting the TCR: T-cell receptor and peptide-specific tolerance-based strategies for restoring self-tolerance in CNS autoimmune disease.

机译:靶向TCR:恢复中枢神经系统自身免疫性疾病自我耐受的基于T细胞受体和肽特异性耐受的策略。

获取原文
获取原文并翻译 | 示例
           

摘要

A principal theme in autoimmunity is the breakdown of central tolerance resulting in the persistence and eventual activation of autoreactive T cells. Because CD4(+) T cells are key contributors to the underlying pathogenic mechanisms responsible for the onset and progression of most autoimmune diseases, they are a logical target for therapeutic interventions. One technique for restoring self-tolerance is to exploit the endogenous regulatory mechanisms that govern CD4(+) T-cell activation. In this review, we discuss promising techniques with the common goal of inducing antigen (Ag)-specific tolerance. Emphasis is given to the use of non-mitogenic anti-CD3 and peptide-specific tolerance strategies that specifically target the T-cell receptor (TCR) in the absence of costimulatory signals. These approaches produce a TCR signal of insufficient strength to cause CD4(+) T-cell activation and instead induce functional T-cell anergy or deletion while avoiding generalized long-term immunosuppression.
机译:自身免疫的一个主要主题是中枢耐受性的破坏,导致自身反应性T细胞的持久性和最终激活。因为CD4(+)T细胞是导致大多数自身免疫性疾病发作和发展的潜在致病机制的关键因素,所以它们是治疗干预的逻辑目标。恢复自我耐受的一种技术是利用控制CD4(+)T细胞活化的内源性调节机制。在这篇综述中,我们讨论了诱导抗原(Ag)特异性耐受的共同目标的有前途的技术。重点是在没有共刺激信号的情况下使用非有针对性的抗CD3和肽特异性耐受策略,这些策略专门针对T细胞受体(TCR)。这些方法产生的强度不足以引起CD4(+)T细胞活化的TCR信号,而是诱导功能性T细胞无反应性或缺失,同时避免普遍的长期免疫抑制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号